Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
An Excursion Through Renowned Western Network programs - 22025 Was Another Exceptionally Hot Year
- 3The 12 biggest space stories of 2025 — according to you
- 4Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- 5Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It
- Ukraine proved this drone-killer works. Now, the West is giving it a shot.
- Uranus's small moons are dark, red, and water-poor
- Asia's Noteworthy Destinations: A Voyager's Aide
- Islamic State group militants claim capture and execution of a Nigerian brigadier general
- Living in the dark: Gaza’s struggle for electricity
- A definitive Manual for Internet Mastering and Expertise Improvement
- NASA's Artemis 2 moon launch seen from space | Space photo of the day for April 2, 2026
- Polar bears are rewiring their own genetics to survive a warming climate
- Rights group: At least 2,500 deaths during protest crackdown in Iran
